IKAROS and MENIN coordinate therapeutically actionable leukemogenic gene expression in MLL-r acute myeloid leukemia
Acute myeloid leukemia (AML) remains difficult to treat and requires new therapeutic
approaches. Potent inhibitors of the chromatin-associated protein MENIN have recently …
approaches. Potent inhibitors of the chromatin-associated protein MENIN have recently …
IKAROS and MENIN coordinate therapeutically actionable leukemogenic gene expression in MLL-r acute myeloid leukemia.
BJ Aubrey, JA Cutler, W Bourgeois, KA Donovan… - Nature Cancer, 2022 - europepmc.org
Acute myeloid leukaemia (AML) remains difficult to treat and requires new therapeutic
approaches. Potent inhibitors of the chromatin-associated protein MENIN have recently …
approaches. Potent inhibitors of the chromatin-associated protein MENIN have recently …
[HTML][HTML] IKAROS and MENIN Coordinate Therapeutically Actionable Leukaemogenic Gene Expression in MLL-r Acute Myeloid Leukaemia
BJ Aubrey, JA Cutler, W Bourgeois, KA Donovan… - Nature …, 2022 - ncbi.nlm.nih.gov
Acute myeloid leukaemia (AML) remains difficult to treat and requires new therapeutic
approaches. Potent inhibitors of the chromatin-associated protein MENIN have recently …
approaches. Potent inhibitors of the chromatin-associated protein MENIN have recently …
IKAROS and MENIN coordinate therapeutically actionable leukemogenic gene expression in MLL-r acute myeloid leukemia
BJ Aubrey, JA Cutler, W Bourgeois… - Nature …, 2022 - mdanderson.elsevierpure.com
Acute myeloid leukemia (AML) remains difficult to treat and requires new therapeutic
approaches. Potent inhibitors of the chromatin-associated protein MENIN have recently …
approaches. Potent inhibitors of the chromatin-associated protein MENIN have recently …
IKAROS and MENIN coordinate therapeutically actionable leukemogenic gene expression in MLL-r acute myeloid leukemia
BJ Aubrey, JA Cutler, W Bourgeois… - Nature …, 2022 - pubmed.ncbi.nlm.nih.gov
Acute myeloid leukemia (AML) remains difficult to treat and requires new therapeutic
approaches. Potent inhibitors of the chromatin-associated protein MENIN have recently …
approaches. Potent inhibitors of the chromatin-associated protein MENIN have recently …
IKAROS and MENIN coordinate therapeutically actionable leukemogenic gene expression in MLL-r acute myeloid leukemia.
BJ Aubrey, JA Cutler, W Bourgeois, KA Donovan… - Nature Cancer, 2022 - europepmc.org
Acute myeloid leukaemia (AML) remains difficult to treat and requires new therapeutic
approaches. Potent inhibitors of the chromatin-associated protein MENIN have recently …
approaches. Potent inhibitors of the chromatin-associated protein MENIN have recently …